Abstract
Advances in high-throughput technologies along with the curation of small-scale experiments has aided in the construction of reference maps of the interactome. These maps are critical to our understanding of genotype-phenotype relationships and disease. However, our knowledge of disease associated genes and the map of the human interactome still remains incomplete. In this study we investigate whether protein–protein interaction networks (PPINs) constructed from either experimental or curated data have an impact upon disease network analysis. An integrative network-driven framework is implemented to integrate diverse heterogeneous data including: gene-expression, PPIN, ontology-based similarity, degree connectivity and betweenness centrality measures to uncover potential Alzhemier disease (AD) candidate genes. Two PPINs have been selected and constructed from (1) experimental high-throughput data and (2) literature-curated sources. Only a marginal overlap of protein pairs between the two PPINs (305 protein pairs) was observed. A total of 17 significant AD gene candidate genes were identified using the literature derived PPIN compared to 20 genes using the PPIN constructed from high-throughput data. Both approaches correctly identified the AD susceptible TRAF1, a critical regulator of cerebral ischaemia–reperfusion injury and neuronal death. Biological process enrichment analysis revealed genes candidates from the literature based PPIN are modulated in AD pathogenesis such as neuron differentiation and involved in KEGG pathways such as neurotrophin signaling pathways. Tissue specific analysis revealed 48 % of AD gene candidates obtained from the literature curated PPIN were expressed in tissues where AD is observed compared to 19 % of gene candidates extracted using the high-throughput PPIN.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Machine Learning and Cybernetics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.